Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo‐Controlled Phase III Trial

OBJECTIVE: To evaluate the efficacy and safety of ustekinumab through 2 years in adult patients with active psoriatic arthritis (PsA). METHODS: A total of 615 adult patients with active PsA were randomized to placebo, ustekinumab 45 mg, or ustekinumab 90 mg, at weeks 0, 4, and every 12 weeks through...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Care Res (Hoboken)
Main Authors: Kavanaugh, Arthur, Puig, Lluís, Gottlieb, Alice B., Ritchlin, Christopher, Li, Shu, Wang, Yuhua, Mendelsohn, Alan M., Song, Michael, Zhu, Yaowei, Rahman, Proton, McInnes, Iain B.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Psoriatic Arthritis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063124/
https://ncbi.nlm.nih.gov/pubmed/26097039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.22645
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados